HPSI0813i-eiqh_3
WTSIi567-A
General
Cell Line |
|
hPSCreg name | WTSIi567-A |
Cite as: | WTSIi567-A (RRID:CVCL_AG93) |
Alternative name(s) |
HPSI0813i-eiqh_3
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Last update | 22nd May 2019 |
User feedback | |
Provider |
|
Generator | Wellcome Sanger Institute (WTSI) |
External Databases |
|
HipSci | HPSI0813i-eiqh_3 |
BioSamples | SAMEA2397899 |
Cellosaurus | CVCL_AG93 |
Wikidata | Q54891365 |
General Information |
|
Publications | |
Projects | |
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information
General Donor Information |
|
Sex | female |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA2397879 |
Ethics
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
Was the consent voluntarily given? | Yes |
Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
If you do not hold the Donor Consent Form, do you know who does? | No |
Alternatives to consent | |
Is there other documentation provided to the donor for consenting purposes? | No |
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
Does consent expressly prevent the derivation of pluripotent stem cells? | No |
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
How may genetic information associated with the cell line be accessed? | |
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | No |
Name of accrediting authority involved? | name: Hampstead Research Ethics Committee; Approval Number: 13/LO/0171 |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | Yes |
Name of accrediting authority involved? | Hampstead Research Ethics Committee |
Approval number | 13/LO/0171 |
hIPSC Derivation
General |
|
Source cell type |
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
|
Source cell origin |
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
|
Source cell line vendor | Cambridge BioResource |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Notes on reprogramming vector detection | CytoTune 1 |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Feeder cells |
Yes |
Passage method |
Enzymatically
Collagenase and Dispase
|
CO2 Concentration | 5 % |
Medium |
Other medium:
Base medium:
|
Characterisation
Analysis of Undifferentiated Cells
Pluripotency Score | Novelty Score | |
48.52 | 1.342 |
Report
HPSI-eiqh.pluritest.pluripotency_score.20170510.png
pluripotency image
HPSI-eiqh.pluritest.novelty_score.20170510.png
novelty image
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
Is there genome-wide genotyping or functional data available? |
Yes
cnv
http://www.hipsci.org/lines/#/lines/HPSI0813i-eiqh_3 Number of regions different from primary tissue: 0; Length of differences from primary tissue: 0 |
Login to share your feedback, experiences or results with the research community.